The largest database of trusted experimental protocols

Ribomax large scale rna production t7 kit

Manufactured by Promega
Sourced in United States

The RiboMAX Large-Scale RNA Production-T7 Kit is a laboratory tool used for in vitro transcription of RNA. It provides the necessary components, including the T7 RNA polymerase, to generate large amounts of RNA from a DNA template.

Automatically generated - may contain errors

9 protocols using ribomax large scale rna production t7 kit

1

Efficient mRNA Synthesis via T7 Polymerase

Check if the same lab product or an alternative is used in the 5 most similar protocols
mRNA preparation was carried out as described by Dmitriev et al. (2007) (link). Briefly, PCR products were obtained with a forward
primer containing the T7 promoter (either the universal primer which anneals to the
vector sequence immediately upstream of insertions,
CGCCGTAATACGACTCACTATAGGGAGCTTATCGATACCGTCG or the T7 promoter-containing gene
specific primer) and reverse primer containing an oligo(dT) stretch of 50 nt
T50AACTTGTTTATTGCAGCTTATAATGG. To introduce stem loop structure, PCR products were
obtained with forward primer containing the T7 promoter:
CGCCGTAATACGACTCACTATAGGGAGTGGACTTCGGTCCACTCCCAGCTTATCGATACCGTCG. To introduce the
CAA6 sequence upstream of the IFRD1 uORF, the following primer was
used: CGCCGtaatacgactcactataGGGCAACAACAACAACAACAACAACATGTATCGTTTTCGATCACAGCTC.
The PCR products were then purified and used as templates for T7 RNA polymerase using
in vitro RNA transcription by T7 RiboMAX Large Scale RNA Production kit (Promega,
Fitchburg Center, WI). For preparation of m7G-capped transcripts the
3′-O-Me-m7GpppG (ARCA cap analogue, New England Biolabs,
Ispwich, MA) was added to the transcription mix without GTP for 5 min to prime
transcripts with cap followed by the addition of GTP (at a ratio of ARCA:GTP 10:1).
The resulting RNAs were purified by LiCl precipitation and examined for integrity by
PAGE.
+ Open protocol
+ Expand
2

Lentivirus-Mediated Knockdown Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT116 and MCF7 cells were grown in DMEM supplemented with 10% FBS. The cells were infected with lentivirus containing short-hairpin RNAs in the presence of 8 μg/ml Polybrene (Sigma) for 24 h in DMEM supplemented with 10% FBS. The infected cells were selected with 2 μg/ml puromycin for an extra 48 h before harvest. The shRNAs were purchase from Open Biosystems. The clone IDs for shPAF1 are TRCN0000010939 (#1) and TRCN0000005454 (#2). The clone IDs for shBRE1A are TRCN0000033875 (#1) and TRCN0000033877 (#2).
For serum starvation experiments, HCT116 cells were transduced with shScr or shPAF1, then 24 h later cells were serum starved for 48 h. For serum stimulation, starved cells transduced with shScr were fed back DMEM supplemented with 10% FBS for 30 min.
For flavopiridol inhibition of pause-release, HCT116 cells transduced with shPAF1 for 3 days were treated with 1 μM flavopiridol (Sigma) for 30 min.
S2 cells were maintained at 2-10e6 cells/mL in SFX medium (containing 1% penicillin/streptomycin) and incubated at 28° C prior to RNAi treatment. Cells were plated at 5e5 cells/mL in 20 mL SFX per T75 flask and treated with 100 μg dsRNA for 5.5 days. dsRNA was generated using T7 RiboMAX Large Scale RNA Production Kit (Promega). Oligo sequences are available in the Extended Experimental Procedures.
+ Open protocol
+ Expand
3

Virus-induced gene silencing of wheat ATG8

Check if the same lab product or an alternative is used in the 5 most similar protocols
The barley stripe mosaic virus (BSMV)-based VIGS method was used to create gene knockdown plants (Ma et al., 2012 (link); Dong et al., 2019 (link)). Briefly, a 283-bp fragment of wheat ATG8 from the conserved coding sequence was amplified and purified, with a same-sized fragment of GFP used as a control. The γ strand of BSMV was then digested in XmacI and fused with the ATG8 or GFP fragment to form the vectors BSMVγ-ATG8 and BSMVγ-GFP, respectively. BSMV-α was then linearized with MIuI, BSMV-β was linearized with SpeI, and BSMVγ-ATG8 and BSMVγ-GFP were linearized with BssHII then the linearized vectors were transcribed in vitro to produce 5ʹ-capped infectious BSMV RNA molecules using the RiboMAX Large-Scale RNA Production-T7 Kit (Promega, Madison, WI, United States), with a cap analog added to the transcription mixture. They were then mechanically infected with a 1:1:1 mixture of RNAα, RNAβ and RNAγ-ATG6, or RNAγ- GFP in 1 × GKP buffer (50 mM Gly, 30 mM K2HPO3, 1% bentonite and 1% kieselguhr). In the field, inoculation of BSMV was performed at the heading stage by inoculating 50 spikes with 20 µL of BSMV-ATG8 or BSMV-GFP transcript mixture, respectively.
+ Open protocol
+ Expand
4

BSMV-VIGS for TaMCA-Id Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cDNA fragment of 170 bp (+512 bp to +680 bp) was employed to acquire TaMCA-Id silenced vector. After this fragment was inserted in BSMVγ plasmid (BSMVγ:TaMCA-Id), the plasmids of BSMVα, BSMVγ:GFP, and BSMVγ:TaMCA-Id were linearized with Mlu I (Takala, Dalian, China). BSMVβ was linearized with Spe I (Takala, Dalian, China). Then, RiboMAX largeScale RNA Production-T7 kit (Promega, USA) was used to in vitro transcribe these linearized plasmids. Ribom 7G Cap Analog (Promega, USA) was employed to produce the 5′-capped BSMV RNA molecules for following BSMV-VIGS inoculated experiments. These experiments (containing vector construction, in vitro transcription, BSMV-VIGS inoculation, TaMCA-Id-silenced seedlings identification, and silence efficiency assessment of TaMCA-Id were conducted as previously described (Yue et al., 2021a (link)). For salt stress, part of the BSMV-VIGS-incubated seedlings with three expanded leaves were exposed to 150 mM NaCl treatment for 6 days. All experiments were repeated at least three times, and 20 seedlings were treated for each repeat. The used primes are present in Supplementary Table 1.
+ Open protocol
+ Expand
5

Wheat TaCDPK27 Silencing via BSMV-VIGS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BSMV-VIGS method was performed to acquire TaCDPK27-silenced wheat seedlings as previously described [48 (link)]. A cDNA fragment of 131 bp (+1612 bp to +1742 bp) was employed to acquire the TaCDPK27-silenced vector. After this fragment was inserted into the BSMVγ plasmid (BSMVγ:TaCDPK27), the plasmids BSMVα, BSMVγ:GFP and BSMVγ:TaCDPK27 were linearized with Mlu I (Takara, Dalian, China). BSMVβ was linearized with Spe I (Takara, Dalian, China). Then, a RiboMAX large-scale RNA Production-T7 kit (Promega, Madison, WI, USA) was used to transcribe these linearized plasmids in vitro. Ribom 7G Cap Analog (Promega, Madison, WI, USA) was employed to produce the 5′-capped BSMV RNA molecules for subsequent BSMV-VIGS inoculation experiments. These experiments (including vector construction, in vitro transcription, BSMV-VIGS inoculation, TaCDPK27-silenced seedling identification, and silencing efficiency assessment of TaCDPK27) were conducted as previously described [45 (link)]. Then, the BSMV-VIGS-inoculated seedlings with three fully expanded leaves were treated with 150 mM NaCl for 6 days. All experiments had at least three separate replications. The primes used are listed in Table 3.
+ Open protocol
+ Expand
6

In Vitro Synthesis of JFH1 RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HCV-pJFH1 construct was linearized with the restriction enzyme XbaI. The linear DNA was used as a template for in vitro transcription to synthesize JFH1 RNA using a Ribomax Large scale RNA production T7 kit (Promega).
+ Open protocol
+ Expand
7

Engineered ZIKV infectious clones

Check if the same lab product or an alternative is used in the 5 most similar protocols
the Q5® site-directed mutagenesis kit (NEB, E0552S) was utilized to introduce single amino acid substitutions (K101R, V110I, P148A, I459V, I607V, and L728F) into the infectious clone of FSS13025 with S139N and M2634V mutants (WT). The infectious clone plasmids were linearized by restriction endonuclease digestion and purified by Phenol/Chloroform extraction. In vitro transcribed viral RNA was prepared using Ribomax T7 large-scale RNA production kit (Promega, P1300) and purified using Purelink RNA mini kit (Thermo Fisher Scientific, 12183018 A). The RNA was then transfected into BHK-21 cells using Lipofectamine 3000 reagent (Thermo Fisher Scientific, L3000001). Culture supernatants were collected after 48–72 h post-transfection, and infectious virions were detected by plaque assay and viral antigen expression was detected with indirect immunofluorescent assay. The titers of virus stocks were determined by plaque assay, and the substitution sites were confirmed by RT-PCR (PrimeScript™ One Step RT-PCR Kit, TaKaRa, RR055A) and DNA sequencing.
+ Open protocol
+ Expand
8

ZIKV Replicon Transfection and Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ZIKV replicon that carries the Renilla Luciferase gene was previously described53 (link). The substitutions were constructed using the Q5 site-directed mutagenesis kit (NEB). Primers used for site-directed mutagenesis were as the same as primers used for the generation of mutant viruses described above. The replicon plasmids were linearized by restriction endonuclease digestion and purified by Phenol/Chloroform extraction. In vitro transcribed viral RNA was prepared using Ribomax T7 large scale RNA production kit (Promega) and purified using Purelink RNA mini kit (Thermo Fisher Scientific). 2 × 104 cells were seeded into each well of 48-well plates and incubated at 37 °C in 5% CO2. One day after seeding, 500 ng of each replicon RNA was transfected into each well of cells using Lipofectamine 3000 reagent (Thermo Fisher Scientific). The cell lysates were collected at the given time points and the luciferase activity assay was performed using the Renilla luciferase assay system (Promega) in a GloMax Discover system (Promega).
+ Open protocol
+ Expand
9

In Vitro sgRNA Transcription

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro sgRNA transcription was performed using the Ribomax T7 large-scale RNA production kit (Promega, #P1300) according to the manufacturer’s instructions. In short, 2–4 μg of template DNA containing a T7 promoter was used for each reaction. The in vitro transcription mixture was incubated at 37 ℃ for 3.5 hr, and RNase-free DNase I was added to remove the DNA template. The transcribed RNAs were treated with alkaline phosphatase (Thermo, #01137175) for 1 hr and cleaned up using an E.Z.N.A. miRNA Kit (Omega, #R6842-01). The final RNA stocks were quantified using a NanoDrop spectrophotometer, aliquoted and stored at –80°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!